Peptide Directory

Peptides, and what the record actually shows

A seller with a GLP-1 on the shelf usually has a peptide next to it. The grouping below runs on the weight of published evidence rather than on the body part being marketed, since the seller page rarely puts those two things side by side. Each guide cites primary research, and a thin record is stated on the card before you click.

Most of the peptides listed here hold no FDA approval and reach patients through compounding pharmacies. Read this as background rather than medical advice, and take any decision to a licensed clinician.

Related: what GLP-1s are prescribed for, by condition and the seller reviews.

A low grade is a finding

A weak grade does not mean the compound does nothing. It means nobody has run the study that would settle it, and that absence is itself the result. Sellers price the promising ones the same as the proven ones.

Compounded is not approved

An FDA approval attaches to a named product from a named manufacturer. A compounded peptide is prepared by a pharmacy against a prescription and carries no such approval. That is how the supply chain works, not an accusation about any one seller.

The headline is rarely the rate

Peptide pricing behaves like GLP-1 pricing. The advertised figure is often a first month, a membership fee, or a multi-month prepay divided out. The seller review is where the standing rate is written down.

Grade A: approved, or strong randomized evidence

An FDA-approved product for this use, or randomized trials large enough to rely on.

Grade B: real trials, real limits

Human trials exist and point one way, but they are small, short, or run in a narrower population than the people being sold it.

Grade C: mechanism and anecdote, not outcomes

A plausible mechanism, animal work, or small uncontrolled series. Nothing here establishes that it does what the seller says in humans.

Glutathione

Grade C

Antioxidant infusions

An antioxidant the body already produces, sold back to it by infusion, injection or capsule for oxidative stress, skin and general wellness.

Listed by 123 sellers on the register →

GHK-Cu

Grade C

Skin & hair repair

A copper-binding tripeptide. Cosmetic topical use is mainstream; the injected version rests on far weaker evidence.

Listed by 53 sellers on the register →

BPC-157

Grade C

Tendon & gut repair

A synthetic peptide fragment with a large following in recovery circles and a thin human evidence base. The healing research behind it was done mostly in animals.

Listed by 40 sellers on the register →

TB-500

Grade C

Soft-tissue recovery

A synthetic fragment of thymosin beta-4, taken for muscle, tendon and soft-tissue recovery and very often stacked with BPC-157.

Listed by 29 sellers on the register →

CJC-1295 / Ipamorelin

Grade C

Own growth-hormone output

Two peptides sold as a single protocol: a GHRH analog alongside a selective secretagogue, both aimed at the body's own growth-hormone output.

Listed by 21 sellers on the register →

Ipamorelin

Grade C

Own growth-hormone output

A selective growth-hormone secretagogue, preferred in practice because it disturbs cortisol and prolactin less than the older alternatives. Taken for sleep, recovery and body composition.

Listed by 13 sellers on the register →

Semax

Grade C

Nootropic claims, Russian drug

A seven-amino-acid analog of an ACTH fragment, registered as nasal drops in Russia and sold in the US as a nootropic. No trial has scored memory or attention in people taking it.

Listed by 23 sellers on the register →

Selank

Grade C

Anxiety claims, Russian trials

A seven-amino-acid relative of the immune peptide tuftsin, developed in Russia and sold here for anxiety and focus. Its human trials are small Russian studies that compared it with benzodiazepines, and none we found used a placebo.

Listed by 7 sellers on the register →

CJC-1295

Grade C

Own growth-hormone output

A long-acting copy of the hormone that tells the pituitary to release growth hormone. Two small 2006 studies showed one injection raises GH and IGF-1 for days; no trial has measured muscle, fat or recovery.

Listed by 1 seller on the register →

Thymosin Alpha-1

Grade C

Immune claims, mixed trials abroad

A 28-amino-acid thymus peptide sold in the US for immune support. It has decades of trials abroad in hepatitis B and sepsis, and the largest, in 1,106 adults with sepsis, found no effect on deaths.

Listed by 3 sellers on the register →

DSIP

Grade C

Sleep claims, 1980s trials

A nine-amino-acid peptide named in 1977 for a brain-wave effect in rabbits and sold now as a sleep aid. Small insomnia trials in the 1980s and 1990s mostly found little benefit, and no receptor for it has been identified.

Listed by 6 sellers on the register →

Grade D: sold well ahead of its evidence

Marketed widely with little or no human outcome data behind the claim.